Basics Theravance Biopharma, Inc. Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged in discovery, research, development and commercialization of human therapeutics. IPO Date: May 16, 2014 Sector: Healthcare Industry: Biotech Market Cap: $702.54M Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 2.13% Avg Daily Range (30 D): $0.17 | 1.41% Avg Daily Range (90 D): $0.17 | 1.56% Institutional Daily Volume Avg Daily Volume: .33M Avg Daily Volume (30 D): .38M Avg Daily Volume (90 D): .27M Trade Size Avg Trade Size (Sh.): 94 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 2,067 Avg Inst. Trade: $1.4M Avg Inst. Trade (30 D): $1.13M Avg Inst. Trade (90 D): $1.12M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.16M Avg Closing Trade (30 D): $.7M Avg Closing Trade (90 D): $.82M Avg Closing Volume: 74.1K     News Aug 13, 2025 @ 2:13 AM Theravance Sales Jump 83 Percent Source: Jesterai Jun 26, 2024 @ 4:57 PM AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bl... Source: Zacks Equity Research Jun 26, 2024 @ 3:28 PM Here's Why You May Invest in Theravance (TBPH) Sto... Source: Zacks Equity Research Jun 21, 2024 @ 1:55 PM Wall Street Analysts Predict a 90.53% Upside in Th... Source: Zacks Equity Research Jun 12, 2024 @ 3:30 PM Theravance Bio (TBPH) Down 6.1% Since Last Earning... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.18 $-.27 $-.31 Diluted EPS $-1.18 $-.27 $-.31 Revenue $ 65.27M $ 15.39M $ 18.75M Gross Profit $ $ $ Net Income / Loss $ -58.33M $ -13.58M $ -15.53M Operating Income / Loss $ -50.18M $ -14.43M $ -9.2M Cost of Revenue $ $ $ Net Cash Flow $ 56.78M $ 72.82M $ 14.42M PE Ratio